Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed: 3,385
Companies: 1,062
Pipeline programs: 18,156

Quick answer

NovaPharmaNews tracks 3,385 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 3,385 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources

Quick answer

aluminum hydroxide

anifrolumab

anifrolumab-fnia

avelumab

belumosudil

belumosudil mesylate

bendroflumethiazide

brodalumab

carglumic acid

delafloxacin meglumine

diatrizoate meglumine

dupilumab

durvalumab

emapalumab

emapalumab-lzsg

flumazenil

flumethasone pivalate

fosaprepitant dimeglumine

gadobenate dimeglumine

gadopentetate dimeglumine

gadoterate meglumine

hepatitis b surface antigens recombinant (s, pre-s1, pre-s2) adsorbed on aluminium hydroxide [produced on genetically engineered murine (c127i) cells]

hydroflumethiazide

iodamide meglumine

Frequently asked questions